Neurocrine Clinical Site

1 Howe Street
New Haven, Connecticut 06519

We've found

1 trials

at this facility

Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New Haven, CT

Use our guide to learn which trials are right for you!